Home LiteratureArticle Details
PMID: 7933132 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Tissue-mediated selection of viral variants: correlation between glycoprotein mutation and growth in neuronal cells.

Journal of virology ·Vol. 68 ·No. 11 ·1994-11-00 ·Pages 7490-6

Villarete L, Somasundaram T, Ahmed R

Abstract

Viral variants with different biological properties predominate in the central nervous system (CNS) and lymphoid tissues of carrier mice infected at birth with the Armstrong strain of lymphocytic choriomeningitis virus. The CNS isolates have the same phenotype as the parental strain and cause acute infections in adult mice, while the spleen-derived isolates cause chronic infections associated with suppressed T-cell responses and susceptibility to opportunistic infections. Our previous studies have identified a single amino acid change in the viral glycoprotein, a phenylalanine-to-leucine (F-->L) mutation at residue 260, that correlates with the tissue-specific selection and the persistent and immunosuppressive phenotype of the spleen isolates (R. Ahmed, C.S. Hahn, T. Somasundaram, L. Villarete, M. Matloubian, and J. H. Strauss, J. Virol. 65:4242-4247, 1991). In this study, we screened viral isolates obtained from the spleen, liver, kidney, and brain of carrier mice for the presence of this mutation and determined the temporal selection of variants as they appear in these organs. We found that this F-->L amino acid change is common to > 90% of the spleen and liver isolates and is selected for rapidly by day 32 postinfection (p.i.). Although the kinetics observed in the kidney are relatively slower than in the spleen and liver, this F-->L mutation predominates in the kidney-derived isolates by 250 days p.i. In contrast, the majority of the CNS isolates retain the parental sequence up to 250 days p.i. In addition, most of the brain isolates replicated efficiently in a neuronal cell line, and this enhanced growth phenotype in neurons correlated with the parental F genotype. This linkage with neurotropism, along with our earlier finding that the F-->L mutation is necessary for enhanced infection of macrophages (M. Matloubian, S. R. Kolhekar, T. Somasundaram, and R. Ahmed, J. Virol. 67:7340-7349, 1993), provides a cellular basis for the molecular changes associated with tissue-specific selection. Taken together, these results suggest that tropism for macrophages is a critical determinant in selection of variants with the F-->L mutation in tissues such as spleen and liver, and tropism for neurons is important in retention of the F genotype in the CNS.

MeSH Terms
Animals Base Sequence Glycoproteins/chemistry,genetics Glycosylation Lymphocytic choriomeningitis virus/genetics,growth & development Mice Mice, Inbred BALB C Molecular Sequence Data Mutation Neurons/virology Oligonucleotide Probes Organ Specificity Phenotype Structure-Activity Relationship Tumor Cells, Cultured Viral Proteins/genetics
Chemicals
Glycoproteins Oligonucleotide Probes Viral Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Villarete L
Department of Microbiology and Immunology, University of California, Los Angeles.
Somasundaram T
Ahmed R
References (49)
49 references, click to expand
  1. Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus.
    Virology. 1987 Mar;157(1):145-55 PMID: 3824905
  2. Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins.
    J Virol. 1987 Apr;61(4):982-5 PMID: 3546729
  3. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.
    J Virol. 1987 May;61(5):1310-7 PMID: 3033261
  4. Virus-lymphocyte interaction: T cells of the helper subset are infected with lymphocytic choriomeningitis virus during persistent infection in vivo.
    J Virol. 1987 May;61(5):1571-6 PMID: 2952807
  5. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.
    Science. 1987 May 15;236(4803):819-22 PMID: 3646751
  6. Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus.
    Curr Top Microbiol Immunol. 1987;134:131-43 PMID: 3107910
  7. Analysis of the genomic L RNA segment from lymphocytic choriomeningitis virus.
    Virology. 1987 Dec;161(2):448-56 PMID: 3318094
  8. Distinct biological and serological properties of human immunodeficiency viruses from the brain.
    Ann Neurol. 1988;23 Suppl:S58-61 PMID: 3258140
  9. T-cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cells.
    Proc Natl Acad Sci U S A. 1988 Apr;85(7):2265-8 PMID: 3258424
  10. Organ-specific selection of viral variants during chronic infection.
    J Exp Med. 1988 May 1;167(5):1719-24 PMID: 3367096
  11. Virus-lymphocyte interactions. III. Biologic parameters of a virus variant that fails to generate CTL and establishes persistent infection in immunocompetent hosts.
    Virology. 1988 Jun;164(2):507-16 PMID: 2967012
  12. Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-).
    Virology. 1988 Jun;164(2):517-22 PMID: 3259346
  13. Virus-induced immunosuppression: a murine model of susceptibility to opportunistic infection.
    J Infect Dis. 1988 Jul;158(1):232-5 PMID: 3392416
  14. Viral persistence.
    Cell. 1989 Feb 24;56(4):517-20 PMID: 2645053
  15. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types.
    J Exp Med. 1989 Oct 1;170(4):1149-63 PMID: 2571666
  16. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.
    Nature. 1989 Nov 30;342(6249):559-61 PMID: 2573841
  17. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis.
    Neuron. 1990 Jul;5(1):1-10 PMID: 2196069
  18. Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice.
    J Exp Med. 1990 Oct 1;172(4):1043-8 PMID: 2212940
  19. In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection.
    J Virol. 1990 Nov;64(11):5611-6 PMID: 1976825
  20. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.
    Nature. 1991 Jan 10;349(6305):167-9 PMID: 1986308
  21. HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies.
    Virology. 1991 Feb;180(2):583-90 PMID: 1989385
  22. Altered host range of HIV-1 after passage through various human cell types.
    Virology. 1991 Mar;181(1):288-94 PMID: 1994578
  23. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.
    J Virol. 1991 Apr;65(4):1863-9 PMID: 1840619
  24. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.
    J Exp Med. 1991 Jul 1;174(1):203-12 PMID: 1905339
  25. Molecular basis of organ-specific selection of viral variants during chronic infection.
    J Virol. 1991 Aug;65(8):4242-7 PMID: 2072451
  26. Protein-protein interactions in lymphocytic choriomeningitis virus.
    Virology. 1991 Aug;183(2):620-9 PMID: 1853564
  27. Abrogation of tolerance to a chronic viral infection.
    J Immunol. 1991 Nov 15;147(10):3521-9 PMID: 1940352
  28. Molecular anatomy of viral persistence.
    J Virol. 1991 Dec;65(12):6381-6 PMID: 1719227
  29. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.
    Virology. 1991 Dec;185(2):661-72 PMID: 1683726
  30. The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism.
    J Virol. 1992 Jan;66(1):305-9 PMID: 1727490
  31. The expression of major histocompatibility complex (MHC) class I antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV).
    J Neuroimmunol. 1992 Feb;36(2-3):193-8 PMID: 1732281
  32. Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid.
    AIDS Res Hum Retroviruses. 1992 Jan;8(1):53-9 PMID: 1736940
  33. Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism.
    J Virol. 1992 Apr;66(4):2588-93 PMID: 1548785
  34. Epstein-Barr virus infection and replication in a human epithelial cell system.
    Nature. 1992 Mar 26;356(6367):347-50 PMID: 1312681
  35. Viral infection of the thymus.
    J Virol. 1992 May;66(5):3155-60 PMID: 1560541
  36. Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques.
    J Virol. 1992 Jun;66(6):3550-6 PMID: 1583723
  37. EBV strain variation: geographical distribution and relation to disease state.
    Virology. 1992 Sep;190(1):168-75 PMID: 1356286
  38. The restricted nature of HIV-1 tropism for cultured neural cells.
    Virology. 1992 Dec;191(2):813-25 PMID: 1448925
  39. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.
    Nature. 1993 Apr 22;362(6422):758-61 PMID: 8469287
  40. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus.
    J Virol. 1993 Dec;67(12):7340-9 PMID: 7693969
  41. IMMUNOFLUORESCENT STUDIES OF THE HISTOPATHOGENESIS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTION.
    J Exp Med. 1964 Nov 1;120:829-40 PMID: 14247723
  42. Immunofluorescence study of the carrier state and mechanism of vertical transmission in lymphocytic choriomeningitis virus infection in mice.
    J Pathol Bacteriol. 1966 Apr;91(2):395-402 PMID: 5331383
  43. Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice.
    J Exp Med. 1972 Apr 1;135(4):860-73 PMID: 4622912
  44. Diversity of lymphocytic choriomeningitis virus: variation due to replication of the virus in the mouse.
    J Gen Virol. 1976 Jan;30(1):113-22 PMID: 1245841
  45. The virology and immunobiology of lymphocytic choriomeningitis virus infection.
    Adv Immunol. 1980;30:275-331 PMID: 6160740
  46. Ultrastructural localization of viral antigens in the CNS of mice persistently infected with lymphocytic choriomeningitis virus (LCMV).
    Am J Pathol. 1983 Jan;110(1):95-100 PMID: 6336906
  47. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains.
    J Gen Virol. 1983 Aug;64 (Pt 8):1689-98 PMID: 6875516
  48. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
    J Exp Med. 1984 Aug 1;160(2):521-40 PMID: 6332167
  49. Protein structure and expression among arenaviruses.
    Curr Top Microbiol Immunol. 1987;133:41-57 PMID: 3549168
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1994-11-00
Pages
7490-6
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC237191
Subset
IM
Grants
NINDS NIH HHS · NS 21496 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com